Skip to main content
logo
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
6.47
+0.16 (2.54%)
Aug 25, 2026, 10:43 AM EDT - Market open

Aclaris Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-75.74-64.92-132.07-88.48-86.91-90.87
Depreciation & Amortization
0.420.450.810.860.80.92
Asset Writedown & Restructuring Costs
--86.916.63--
Stock-Based Compensation
11.6612.3810.8620.5415.0414.06
Other Operating Activities
0.82.32.5-27.274.725.09
Change in Accounts Receivable
-1.496.14-4.880.190.140.15
Change in Accounts Payable
6.78.45-4.19-1.470.373.66
Change in Unearned Revenue
-3.85-3.8223.93---
Change in Other Net Operating Assets
-0.55-8.1-3.9410.68-1.7-5.15
Operating Cash Flow
-62.06-47.11-20.08-78.33-67.57-52.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.12-0.11-0.12-1.31-0.61-0.31
Sale (Purchase) of Intangibles
--0.83-35.81---
Investment in Securities
3.6549.31-33.8447.5313.23-167.32
Investing Cash Flow
3.5348.37-69.7746.2212.63-167.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------11.48
Net Debt Issued (Repaid)
------11.48
Issuance of Common Stock
58.15-80.0327.6372.9239.66
Repurchase of Common Stock
-0.44-0.45-0.41-0.1-0.03-3.12
Other Financing Activities
-5.42-5.42-5.09-0.83--
Financing Cash Flow
52.29-5.8674.5426.7172.87225.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-6.24-4.61-15.31-5.417.935.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-62.18-47.22-20.2-79.63-68.17-52.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-756.50%-603.42%-107.89%-254.84%-229.13%-775.65%
Free Cash Flow Per Share
-0.48-0.39-0.26-1.14-1.04-0.92
Levered Free Cash Flow
-41.97-30.63-59.12-37.97-39.31-28.51
Unlevered Free Cash Flow
-41.97-30.63-59.12-37.97-39.31-28.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.82.6710.929.39-1.2-1.34
SEC Filings: 10-K · 10-Q